文献速递冠心病外科

实体器官移植前接受外科冠脉血运重建的结局

Outcomes of Surgical Coronary Revascularization Performed Before Solid Abdominal Organ Transplants.
PubMed 文献 · Ann Thorac Surg · 2020-07-09

该回顾性研究分析了2010至2016年间单中心1801例孤立CABG患者,其中28例为等待肾或肝移植的移植前患者。移植前组术后30天死亡率、神经系统事件和再插管率均显著高于非移植组,且多数患者最终未接受器官移植。

要点

  • 移植前CABG组30天死亡率为14.3%,显著高于非移植组的2.8%。
  • 移植前组仅3例(10.7%)最终接受肾移植,无肝移植发生。
  • 移植前组1年和5年死亡率分别为17.9%和53.6%。

核心结论

  • 肾移植前和肝移植前患者接受CABG的结局较差,尽管进行了外科血运重建,大多数患者最终未接受器官移植。

研究设计与样本

  • 回顾性分析2010至2016年印第安纳大学医学院所有孤立CABG患者,分为移植前组(28例,肾22例、肝7例)和非移植组(1773例),比较基线特征和术后结局。

主要发现

  • 移植前组30天死亡率14.3% vs 非移植组2.8%(P = .009)。
  • 移植前组神经系统事件17.9% vs 4.8%(P = .011)。
  • 移植前组再插管21.4% vs 5.8%(P = .005)。
  • 移植前组术后总通气时间5.2小时 vs 5.0小时(P = .0124)。
  • 移植前组1年和5年死亡率分别为17.9%和53.6%,3例(10.7%)接受肾移植,无肝移植。

临床怎么用

  • 对等待肾或肝移植的终末期器官疾病患者行CABG前,应充分评估高死亡风险和术后并发症风险。
  • 需向患者告知即使完成血运重建,最终接受器官移植的可能性仍较低。

局限性

  • 本研究为单中心回顾性分析,移植前组样本量小(28例),可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac risk stratification and coronary angiography are routinely performed as part of kidney and liver transplant candidacy evaluation. There are limited data on the outcomes of surgical coronary revascularization in this patient population. This study investigated outcomes in patients with end- stage renal or hepatic disease who were undergoing coronary artery bypass grafting (CABG) to attain kidney or liver transplant candidacy. METHODS: This study was a retrospective analysis of all patients who underwent isolated CABG at our institution, Indiana University School of Medicine (Indianapolis, IN), between 2010 and 2016. Patients were divided into 2 cohorts: pretransplant (those undergoing surgery to attain renal or hepatic transplant candidacy) and nontransplant (all others). Baseline characteristics and postoperative outcomes were compared between the groups. RESULTS: A total of 1801 patients were included: 28 in the pretransplant group (n = 22, kidney; n = 7, liver) and 1773 in the nontransplant group. Major adverse postoperative outcomes were significantly greater in the pretransplant group compared with the nontransplant group: 30-day mortality (14.3% vs 2.8%; P = .009), neurologic events (17.9% vs 4.8%; P = .011), reintubation (21.4% vs 5.8%; P = .005), and total postoperative ventilation (5.2 hours vs 5.0 hours; P = .0124). The 1- and 5-year mortality in the pretransplant group was 17.9% and 53.6%, respectively. Of the pretransplant cohort, 3 patients (10.7%) underwent organ transplantation (all kidney) at a mean 436 days after CABG. No patients underwent liver transplantation. CONCLUSIONS: Outcomes after CABG in pre-kidney transplant and pre-liver transplant patients are poor. Despite surgical revascularization, most patients do not ultimately undergo organ transplantation. Revascularization strategies and optimal management in this high-risk population warrant further study.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Matthews CR, Millward JB, Faiza Z, et al. Outcomes of Surgical Coronary Revascularization Performed Before Solid Abdominal Organ Transplants. Ann Thorac Surg. 2020. PMID: 32652071. doi:10.1016/j.athoracsur.2020.05.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。